(Q44083625)
Statements
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720 (English)
Clara D Bloomfield
2 references
Michael A Caligiuri
Richard A Larson
Jonathan E Kolitz
Charles A Schiffer
Bayard L Powell
Maria R Baer
Stephen L George
Richard K Dodge
Kieran L O'Loughlin
Hans Minderman
1 August 2002